Pap-HPV co-testing adoption trends for cervical cancer screening in a multi-state Practice Research Network (PBRN) 2012-2017

被引:0
|
作者
Shin, Michelle
West, Imara
Hsu, Chialing
Prado, Maria
Tsui, Jennifer
Ko, Linda
Winer, Rachel
Cole, Allison
机构
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页数:2
相关论文
共 4 条
  • [1] The Efficacy of HPV16/18 Genotyping in Women with Pap-/HPV plus Co-testing Results in a Cervical Cancer Screening Population and a Cancer Surveillance Population
    Mousavi, Shima
    Kundu, Uma
    Guo, Ming
    LABORATORY INVESTIGATION, 2019, 99
  • [2] The Efficacy of HPV16/18 Genotyping in Women with Pap-/HPV plus Co-testing Results in a Cervical Cancer Screening Population and a Cancer Surveillance Population
    Mousavi, Shima
    Kundu, Uma
    Guo, Ming
    MODERN PATHOLOGY, 2019, 32
  • [3] Cervical cancer rates in clinical practice with co-testing, interval extension and current evaluation of women with pap-negative, human papillomavirus-positive screening tests
    Dinkelspiel, H.
    Poitras, N.
    Fetterman, B.
    Kinney, W.
    Cox, T.
    Lorey, T.
    Castle, P.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S19 - S19
  • [4] Early detection of CIN3 and cervical cancer during long-term follow-up using HPV/Pap smear co-testing and risk-adapted follow-up in a locally organised screening programme
    Luyten, Alexander
    Buttmann-Schweiger, Nina
    Luyten, Katrin
    Mauritz, Claudia
    Reinecke-Luethge, Axel
    Pietralla, Martina
    Meijer, Chris J. L. M.
    Petry, Karl Ulrich
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (06) : 1408 - 1416